Showing results (521-530 of 585) with videos related to

Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global StudySai-Hong Ignatius Ou, Jin Seok Ahn, Luigi De Petris, et al.
Scientific Reports|November 26, 2024
Impact of a two step antimicrobial stewardship program in a paediatric haematology and oncology unitCecilia Liberati, Elisa Barbieri, Francesca Cavagnero, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2019
Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancerSai-Hong Ignatius Ou, Shirish M Gadgeel, Fabrice Barlesi, et al.
International Journal of Cancer|August 4, 2020
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosisHelena Liljedahl, Anna Karlsson, Gudrun N Oskarsdottir, et al.
Nature Medicine|June 5, 2020
Author Correction: Caring for patients with cancer in the COVID-19 eraJoris van de Haar, Louisa R Hoes, Charlotte E Coles, et al.
Plos One|January 24, 2019
The lost children: The underdiagnosis of dyslexia in Italy. A cross-sectional national studyChiara Barbiero, Marcella Montico, Isabella Lonciari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2017
Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung CancerJames Chih-Hsin Yang, Sai-Hong Ignatius Ou, Luigi De Petris, et al.
Nature Medicine|May 15, 2020
Caring for patients with cancer in the COVID-19 eraJoris van de Haar, Louisa R Hoes, Charlotte E Coles, et al.
Pageof 59